{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:29:18Z","timestamp":1777724958800,"version":"3.51.4"},"reference-count":28,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Int Med Res"],"published-print":{"date-parts":[[1993,1]]},"abstract":"<jats:p>The common causes of vaginitis have changed in recent years. Infection with Trichomonas vaginalis is much less frequent than it used to be. The most common causes of vaginitis are candidiasis and bacterial vaginosis due to infection with mixed bacterial flora. In general practice, treatment of vaginitis is often begun before microbiological confirmation of the diagnosis is available. A vaginal pessary has been formulated to provide an effective therapy in all three forms of vaginitis mentioned above. This formulation, Neotran\u00ae, is believed to be the first pessary to contain both metronidazole and miconazole. In vivo and in vitro studies showed Neotran\u00ae to be effective against Candida albicans and mixed bacterial flora. Neotran\u00ae was shown, in vitro, to be active against Trichomonas but, because of the current rarity of trichomonal infection in the UK, it was not possible to show its effectiveness against Trichomonas in vivo. In a general-practice clinical trial of the treatment of vaginitis in 80 patients, Neotran\u00ae pessaries achieved a microbiological resolution rate of 83% in those patients who were bacteriologically evaluable and was well tolerated. Overall clinical evaluation of the patients showed the condition to be resolved in 73% of patients, improved in 21% and unchanged in 6%.<\/jats:p>\n                  <jats:p>Die gew\u00f6hnlichen Ursachen von Vaginitis haben sich in den vergangenen Jahren ge\u00e4ndert. Eine Infektion mit Trichomonas vaginalis ist viel seltener als fr\u00fcher. Die gew\u00f6hnlichsten Ursachen von Vaginitis sind Candidiase und bakterielle Vaginose aufgrund von Infektionen mit gemischter bakterieller Flora. In der Allgemeinmedizin wird die Behandlung von Vaginitis oft begonnen, bevor eine mikrobiologische Best\u00e4tigung der Diagnose zur Verf\u00fcgung steht. Es wurde ein Scheidenpessar hergestellt, um eine wirksame Behandlung aller der drei oben angegebenen Arten von Vaginitis zu erm\u00f6glichen. Es besteht die Meinung, da\u03b2 Neotran\u00ae, eine Mischung nach Formel, das erste Pessar ist, das sowohl Metronidazole als auch Miconazole enth\u00e4lt. Studien in vivo und in vitro zeigten, da\u03b2 Neotran\u00ae gegen Candida albicans und gemischte bakterielle Flora wirksam ist. Neotran\u00ae erwies sich in vitro aktiv gegen Trichomonas, es war aber wegen der derzeitigen Seltenheit von trichomonalen Infektionen in Gro\u03b2britannien nicht m\u00f6glich, ihre Wirksamkeit gegen Trichomonas in vivo aufzuzeigen. In klinischen Versuchen, die in der Allgemeinmedizin bei der Behandlung von Vaginitis ausgef\u00fchrtwurden, bewirkten die Neotran\u00ae-Pessare bei 80 Patienten eine mikrobiologische Aufl\u00f6sungsrate von 83% bei jenen Patienten, die bakteriologisch bewertet werden konnten, und sie wurden gut toleriert. Eine allgemeine klinische Bewertung der Patienten zeigte, da\u03b2 der Zustand bei 73% der Patienten geheilt, bei 21% verbessert und bei 6% unver\u00e4ndert war.<\/jats:p>\n                  <jats:p>Son yillarda vajinitis'in bilinen yaygin sebeplerinde de\u011fi\u015fLmeler olmu\u015fLtur. Trichomonas vaginalis ile olu\u015fLan vajinitis artik eskisine oranla \u00e7ok seyrek olarak g\u00f6r\u00fclmektedir. Vajinitis'in en yaygin sebepleri; candidiasis ve kari\u015fLik flora ile olu\u015fLmu\u015fL enfeksiyona ba\u011fli bakteriyel vajinosistir. Klinik uy\u011fulamada, vajinitis'in tedavisi genellikle, daha mikrobiyolojik k\u00fclt\u00fcr sonucu gelmeden ba\u015fLlar. Yukarida siralanan \u00fc\u00e7 vajinitis t\u00fcr\u00fcne etkili olabilecek yeni bir vajinal ov\u00fcl tedavi hizmetine sunulmu\u015fLtur. Bu ov\u00fcl Neotran\u00ae olup, hem metranidazol hem de micanozole i\u015fLeren ilk ov\u00fcld\u00fcr. In vivo ve in vitro ara\u015fLtirmalar Neotran\u00ae\u2019 in hem Candida albicans'a hem de kari\u015fLik flora bakterilerine kar\u015fLi etkili oldu\u011funu g\u00f6stermi\u015fLter. Neotran\u00ae'in ashnda in vitro olarak Trichomonas'a kar\u015fLi da etkili oldu\u011fu ara\u015fLtirmalar sonucunda ortaya \u00e7ikmi\u015fLtir; ama Ingiltere'de trikomonal enfeksiyon \u00e7ok seyrek oldu\u011fu i\u00e7in, in vivo olarak bu etkinli\u011fi g\u00f6stermek m\u00fcmk\u00fcn olmami\u015fLtir. Seksen hastayi i\u00e7ine alan bir ara\u015fLtirmada Neotran\u00ae, hastalarin %83\u2019 \u00fcnde mikrobiyolojik d\u00fczelme sa\u011flami\u015fLtir. Ayrica bu hastalar Neotran\u00ae\u2019 i iyi tolere etmi\u015fLtir. Bu hastalarin genel de\u011ferlendirmeleri sonucunda %73 vakada klinik \u015fLikayetlerin kayboldu\u011fu, %6\u2019 sinda hi\u00e7 bir de\u011fi\u015fLme olmadi\u011fi ve %21\u2019 inde \u015fLikayetlerin kismen iyile\u015fLti\u011fi g\u00f6r\u00fclm\u00fc\u015fLt\u00fcr.<\/jats:p>","DOI":"10.1177\/030006059302100104","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T02:41:38Z","timestamp":1484534498000},"page":"36-46","source":"Crossref","is-referenced-by-count":5,"title":["Neotran\u00ae \u2013 A New Double-Active Pessary for the Treatment of Vaginitis"],"prefix":"10.1177","volume":"21","author":[{"given":"O","family":"Morton","sequence":"first","affiliation":[{"name":"London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1993,1,1]]},"reference":[{"key":"bibr1-030006059302100104","first-page":"54","volume":"18","author":"Brocklehurst P","year":"1991","journal-title":"Br J Sex Med"},{"key":"bibr2-030006059302100104","first-page":"232","volume":"234","author":"Scott E","year":"1990","journal-title":"Practitioner"},{"key":"bibr3-030006059302100104","first-page":"38","volume":"18","author":"Mohanty KC","year":"1991","journal-title":"Br J Sex Med"},{"key":"bibr4-030006059302100104","first-page":"85","volume":"32","author":"Douglas CP","year":"1986","journal-title":"Update"},{"key":"bibr5-030006059302100104","first-page":"1004","volume-title":"The Pharmacological Basis of Therapeutics","author":"Webster LT","year":"1985","edition":"7"},{"key":"bibr6-030006059302100104","first-page":"368","volume":"12","author":"Blackwell A","year":"1987","journal-title":"Matern Child Health"},{"key":"bibr7-030006059302100104","first-page":"235","volume":"16","author":"Singha HSK","year":"1989","journal-title":"Br J Sex Med"},{"key":"bibr8-030006059302100104","doi-asserted-by":"publisher","DOI":"10.1177\/095646249200300106"},{"key":"bibr9-030006059302100104","volume-title":"18th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, Georgia","volume":"1978","author":"Opperman JA","year":"1978"},{"key":"bibr10-030006059302100104","doi-asserted-by":"publisher","DOI":"10.1159\/000238152"},{"key":"bibr11-030006059302100104","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(74)90028-8"},{"key":"bibr12-030006059302100104","first-page":"668","volume":"223","author":"Tooley P","year":"1989","journal-title":"Practitioner"},{"key":"bibr13-030006059302100104","doi-asserted-by":"publisher","DOI":"10.1159\/000298944"},{"key":"bibr14-030006059302100104","doi-asserted-by":"publisher","DOI":"10.3109\/02813439008994962"},{"key":"bibr15-030006059302100104","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.295.6603.886"},{"key":"bibr16-030006059302100104","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/16.2.189"},{"key":"bibr17-030006059302100104","first-page":"389","volume":"98","author":"Meech RJ","year":"1985","journal-title":"NZ Med J"},{"key":"bibr18-030006059302100104","doi-asserted-by":"publisher","DOI":"10.3109\/00365548909037890"},{"key":"bibr19-030006059302100104","first-page":"107","volume":"40","author":"Hovic P","year":"1983","journal-title":"Scand J Infect Dis [Suppl]"},{"key":"bibr20-030006059302100104","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03490010094036"},{"key":"bibr21-030006059302100104","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1742-1241.1989.tb08728.x","volume":"43","author":"Dinsmore WW","year":"1989","journal-title":"Br J Clin Pract"},{"key":"bibr22-030006059302100104","doi-asserted-by":"publisher","DOI":"10.3109\/00016348309156251"},{"key":"bibr23-030006059302100104","first-page":"270","volume":"61","author":"Bradbeer CS","year":"1985","journal-title":"Genitourin Med"},{"key":"bibr24-030006059302100104","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.1991.tb02798.x"},{"key":"bibr25-030006059302100104","first-page":"561","volume":"36","author":"Corson SL","year":"1991","journal-title":"J Reprod Med"},{"key":"bibr26-030006059302100104","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(78)90900-6"},{"key":"bibr27-030006059302100104","first-page":"479","volume":"34","author":"Kaufman RH","year":"1989","journal-title":"J Reprod Med"},{"key":"bibr28-030006059302100104","first-page":"1045","volume":"31","author":"Brown D","year":"1986","journal-title":"J Reprod Med"}],"container-title":["Journal of International Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/030006059302100104","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/030006059302100104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:41:14Z","timestamp":1777459274000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/030006059302100104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,1]]}},"alternative-id":["10.1177\/030006059302100104"],"URL":"https:\/\/doi.org\/10.1177\/030006059302100104","relation":{},"ISSN":["0300-0605","1473-2300"],"issn-type":[{"value":"0300-0605","type":"print"},{"value":"1473-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1]]}}}